Critical Outcome Technologies, Inc.

Ordinary Shares International Reporting
Verified Company Profile 11/29/2016
Contact Info
  • 700 Collip Circle
  • Suite 213
  • London, ONT N6G4X8
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jul 31, 2016 Quarterly Report
CIK 0001585808
Fiscal Year End 4/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Business Status Development Stage Company a/o
Incorporated In: Canada
Year of Inc. 2008
Employees 9 a/o Jul 05, 2016
Company Officers/Contacts
Dr. Wayne Danter CEO
Alison Silva President
Gene Kelly CFO
Company Directors
John Drake Chairman
Douglas Alexander
Dr. Bharatt Chowrira
Dr. Wayne Danter
Bruno Maruzzo
David Sanderson
Alison Silva
John Yoo
Service Providers
Accounting/Auditing Firm
140 Fullarton Street
Suite 1400
London, ONT, N6A 5P2

Legal Counsel
McMillan LLP
181 Bay Street
Suite 4400
Toronto, ONT, M5J 2T3

Investor Relations Firm
Outreach 99 LLC
37 Oyster Shell Lane
East Falmouth, MA, 02536
United States

COTQF Security Details
Share Structure
Market Value1 $52,844,744 a/o Dec 02, 2016
Authorized Shares Unlimited a/o Nov 22, 2016
Outstanding Shares 148,858,435 a/o Oct 27, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 129,717,935 a/o Oct 31, 2016
Par Value No Par Value
Shareholders of Record 2,185 a/o Oct 31, 2016
Non US Stock Exchange Listing
COT - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 680 (-68.84%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security